D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -37.52% -71.14% -75.27% -86.87% -75.46%
Total Depreciation and Amortization 30.64% 28.24% 14.87% -4.09% -4.06%
Total Amortization of Deferred Charges 0.00% 0.00% 0.00% 0.00% 0.00%
Total Other Non-Cash Items -23.42% 28.13% 20.15% 24.32% 41.22%
Change in Net Operating Assets -98.90% -1,127.01% -298.34% 19.43% 372.46%
Cash from Operations -59.01% -84.96% -109.76% -93.73% -56.23%
Capital Expenditure -33.37% -37.58% -12.29% 14.48% 28.54%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -62.48% -1,460.65% -169.04% -995.07% -2,417.81%
Cash from Investing -61.82% -1,865.12% -160.49% -826.90% -1,320.63%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 120.11% -80.02% -98.28% -88.97% 30.19%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -88.62% 2,001,885.71% 2,001,885.71% 2,001,885.71% 2,001,885.71%
Cash from Financing -21.95% 109.64% 23.26% 44.85% 307.79%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -128.43% -186.97% -137.83% -141.72% 913.00%
Weiss Ratings